ONE Bio Corp. (ONBI)
OTCMKTS · Delayed Price · Currency is USD
0.0200
+0.0198 (9,900.00%)
At close: Oct 3, 2025
ONE Bio Revenue
ONE Bio had revenue of $13.54M in the quarter ending September 30, 2011, with 0.26% growth. This brings the company's revenue in the last twelve months to $53.91M, up 6.13% year-over-year. In the year 2010, ONE Bio had annual revenue of $52.30M with 136.92% growth.
Revenue (ttm)
53.91M
Revenue Growth
+6.13%
P/S Ratio
0.00
Revenue / Employee
150.58K
Employees
358
Market Cap
167.40K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2010 | 52.30M | 30.22M | 136.92% |
| Dec 31, 2009 | 22.07M | 11.67M | 112.21% |
| Dec 31, 2008 | 10.40M | 10.26M | 7,250.54% |
| Dec 31, 2007 | 141.51K | -66.00K | -31.81% |
| Dec 31, 2006 | 207.51K | 43.73K | 26.70% |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
ONE Bio News
- 2 years ago - Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal - Seeking Alpha